Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL3702836 |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
ribosomal protein S6 kinase A3/Ribosomal protein S6 kinase alpha 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2345] [GtoPdb: 1528] [UniProtKB: P51812] | ||||||||
ChEMBL | Binding affinity to RPS6KA3 (unknown origin) | B | 9.27 | pKd | 0.54 | nM | Kd | Eur J Med Chem (2018) 151: 315-326 [PMID:29631132] |
Bruton tyrosine kinase/Tyrosine-protein kinase BTK in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5251] [GtoPdb: 1948] [UniProtKB: Q06187] | ||||||||
ChEMBL | Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). | B | 8.68 | pIC50 | 2.1 | nM | IC50 | US-8940744-B2. Pyrazolopyrimidine compounds as kinase inhibitors (2015) |
ChEMBL | Caliper-Based Kinase Assay: A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of Btk kinase activity of a compound of the present disclosure. Serial dilutions of test compounds were incubated with human recombinant Btk (0.5 nM), ATP (16 μM) and a phosphoacceptor peptide substrate FAM-GEEPLYWSFPAKKK-NH2 (1 μM) at room temperature for 3 h. The reaction was then terminated with EDTA, final concentration 20 mM and the phosphorylated reaction product was quantified on a Caliper Desktop Profiler (Caliper LabChip 3000). | B | 8.68 | pIC50 | 2.1 | nM | IC50 | US-9266895-B2. Substituted pyrazolo[3,4-d]pyrimidines as kinase inhibitors (2016) |
GtoPdb | - | - | 8.72 | pIC50 | 1.9 | nM | IC50 | Nat Chem Biol (2015) 11: 525-31 [PMID:26006010] |
ChEMBL | Inhibition of BTK (unknown origin) | B | 8.72 | pIC50 | 1.9 | nM | IC50 | Eur J Med Chem (2018) 151: 315-326 [PMID:29631132] |
erb-b2 receptor tyrosine kinase 4 in Human [GtoPdb: 1799] [UniProtKB: Q15303] | ||||||||
GtoPdb | - | - | 7.19 | pIC50 | 65 | nM | IC50 | Nat Chem Biol (2015) 11: 525-31 [PMID:26006010] |
BLK proto-oncogene, Src family tyrosine kinase in Human [GtoPdb: 1940] [UniProtKB: P51451] | ||||||||
GtoPdb | - | - | 7.17 | pIC50 | 68 | nM | IC50 | Nat Chem Biol (2015) 11: 525-31 [PMID:26006010] |
BMX non-receptor tyrosine kinase in Human [GtoPdb: 1942] [UniProtKB: P51813] | ||||||||
GtoPdb | - | - | 8.12 | pIC50 | 7.6 | nM | IC50 | Nat Chem Biol (2015) 11: 525-31 [PMID:26006010] |
tec protein tyrosine kinase in Human [GtoPdb: 2238] [UniProtKB: P42680] | ||||||||
GtoPdb | - | - | 8.47 | pIC50 | 3.4 | nM | IC50 | Nat Chem Biol (2015) 11: 525-31 [PMID:26006010] |
TXK tyrosine kinase in Human [GtoPdb: 2268] [UniProtKB: P42681] | ||||||||
GtoPdb | - | - | 7.39 | pIC50 | 41 | nM | IC50 | Nat Chem Biol (2015) 11: 525-31 [PMID:26006010] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]